Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancer.
Zaczek AJ, Markiewicz A, Seroczynska B, Skokowski J, Jaskiewicz J, Pienkowski T, Olszewski WP, Szade J, Rhone P, Welnicka-Jaskiewicz M, Jassem J.
Zaczek AJ, et al. Among authors: markiewicz a.
Oncologist. 2012;17(10):1246-55. doi: 10.1634/theoncologist.2012-0023. Epub 2012 Aug 7.
Oncologist. 2012.
PMID: 22871798
Free PMC article.